Industry Analysis
Innoscience’s successful injunction against Infineon at electronica China marks a strategic inflection: Chinese GaN players are no longer just scaling production but actively reshaping IP governance. Technically, uncertainty around GaN-on-Si patents could delay integration into sub-3nm power delivery stacks, undermining EUV node efficiency gains. Compliance-wise, global suppliers now face mandatory pre-launch IP audits in China—or risk exhibition bans and channel blacklisting. Competitors from Taiwan, China and U.S. IDMs will likely hedge by co-developing with local IP pools. Over the next 18 months, China’s GaN market will bifurcate: firms holding core epitaxial or gate-process patents will set de facto standards, while others retreat to niche or white-label roles.
This page displays AI-generated summaries and metadata for research purposes. Original content belongs to the respective publishers.